Analyst Ratings for Immunovant (IMVT)
IMVT Rating Summary
IMVT Price Target Summary
- Highest: $27.00 (Wells Fargo)
- Lowest: $5.00 (UBS)
- Average: $15.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$15.25 (-13.9%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 44%

Rating Score: 4.5 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/3/2023 | Wells Fargo | Chris M. Carey | Upgrade | Overweight (Equal Weight) |
27.00 (10.00) |
17.41 (17.72) |
1.78% | Details |
9/26/2022 | UBS | Colin Bristow | Downgrade | Neutral (Buy) |
5.00 (7.00) |
5.13 (17.72) |
245.42% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |